Multicenter, randomised, double-blind phase III trial to investigate the efficacy and safety of BIBF 1120 in combination with carboplatin and paclitaxel compared to placebo plus carboplatin and paclitaxel in patients with advanced ovarian cancer
Trial Number
NCT01015118Contact Person
Status
Completed
Disease Site
Ovarian
Lead Cooperative Group
Participating Groups
AGO-AUST
BGOG
DGOG
GEICO
GINECO
MaNGO
MITO
NSGO-CTU